New locations in Greensburg and Wayne expand the Company’s retail presence to 14 locations in one of the country’s largest medical markets
January 20, 2022 —Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today announced plans to open two new dispensaries in Pennsylvania. Curaleaf’s latest locations in Greensburg and Wayne will increase the Company’s retail footprint to 14 dispensaries statewide and 125 across the country. Two additional locations, Curaleaf Erie (7891 Peach St.) and Curaleaf State College (1248 S Atherton St.), are expected to open by the end of February, pending regulatory approval.
Curaleaf Greensburg, located at 5133 US-30, is the first of the dispensaries to hold a Grand Opening today, January 20. Curaleaf Wayne, located at 707 Lancaster Ave., has already undergone a soft opening and will celebrate its Grand Opening on Thursday, January 27. The Company’s newest retail locations are dedicated to being a leading resource in research-based patient education and advocacy. Patients will have access to a selection of Curaleaf’s top-selling vaporizer and whole flower products, including Select Elite, Select Elite Live, Grassroots Full-Spectrum RSOs, RSO capsules, prepackaged flower, distillate cartridges, strain-specific vape cartridges, as well as cured and live concentrates.
Since becoming a Clinical Registrant recognized by the Commonwealth’s Department of Health in 2020, Curaleaf’s Pennsylvania subsidiaries have supported research initiatives examining the potential benefits of cannabis by providing medical marijuana and guidance to patients. Curaleaf’s first-in-the-nation research program builds upon the Company’s ongoing efforts to provide clinically supported resources to Pennsylvania’s over 681,000 registered patients.
“Curaleaf is proud to broaden its scope of patient care and provide premium medical marijuana products to our Greensburg and Wayne medical communities,” said Chief Executive Officer Joe Bayern. “Our latest retail expansion allows us to further support patients in the state of Pennsylvania and work with esteemed scientists on essential medical marijuana studies that will empower both physicians and patients to make confident and informed decisions.”
In addition to Curaleaf’s latest two locations, the Company also serves patients through its Curaleaf dispensaries in Altoona, Bradford, Brookville, City Avenue, DuBois, Gettysburg, Harrisburg, Horsham, King of Prussia, Lebanon, Morton and Philadelphia. In the coming weeks, Curaleaf will offer grand opening discounts to veterans, seniors and first-time patients at all Pennsylvania locations. For more information on store openings, along with product offerings and hours of operation, please visit https://curaleaf.com/locations#pennsylvania.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 23 states with 125 dispensaries, 25 cultivation sites, and employs over 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.